Evidence map›Paper›PMID 41057796›Full record

ArticleBMC plant biology2025

Integrated metabolomic and transcriptomic profiling reveals leaf-specific flavonoid biosynthesis in Paris polyphylla Sm.

Wang Yang, Zhihao Li, Juncheng Lin, Changhu Ke, Huimin Liu, Fangling Ren, Huilin Huang, Pengju Wang, Lun Wu, Tingwen Ming and 2 more

Abstract read
In one paragraph

Article in BMC plant biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Wang Yang *Sinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Zhihao Li *Sinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Juncheng LinSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Changhu KeSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Huimin LiuSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Fangling RenSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Huilin HuangSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Pengju WangSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Lun WuSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Tingwen MingSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China.
Jingjian LiuSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China. liujj95@163.com.
Peng LiSinopharm Dongfeng General Hospital, School of Pharmaceutical Sciences, Hubei University of Medicine, Shiyan, 442000, Hubei, China. dfyylp@163.com.

Funding

the Natural Science Foundation of Hubei Provincial Department of Education No. B2023108, B2023109the Open Project of Hubei Key Laboratory of Wudang Local Chinese Medicine Research, Hubei University of Medicine NO. WDCM2022012, WDCM2024024the Project of Guangdong Provincial Administration of Traditional Chinese Medicine NO. 20252037the Scientific and Technological Project of Shiyan City of Hubei Province No. 24Y138, 24Y139This research was funded by the 2023-2024 scientific research projects of traditional Chinese medicine of Hubei Provincial Administration of traditional Chinese Medicine NO. ZY2023F075
6 · The paper itself

Abstract

backgroundParis polyphylla Sm. is a precious medicinal plant rich in various active ingredients. In addition to the well-known saponins, the flavonoids it contains have unique pharmacological potential in antioxidant, neuroprotective, and metabolic regulation. However, the flavonoids in Paris polyphylla Sm. have not been fully researched and developed yet. In this work, we conducted a comprehensive metabolomics and transcriptomics analysis to reveal the metabolic differences and biosynthetic mechanisms of flavonoids in the leaves, stems, and roots of Paris polyphylla Sm.

resultsNon-targeted metabolomics analysis detected a total of 332 metabolites in Paris polyphylla Sm., among which flavonoids accounted for 19.49%. The diversity and abundance of flavonoids in leaves are the highest, followed by stems and roots. By comparing the metabolites of the roots, stems, and leaves in Paris polyphylla Sm., it was found that there were 45 differential metabolites (DMs) between the leaves and roots, of which flavonoids accounted for 35%. There are 38 DMs between leaves and stems, of which flavonoids account for 45.45%. And there are 52 DMs in stems and roots, among which flavonoids account for 25.53%. A total of 62,766 genes were detected by transcriptomics, and pairwise comparison showed that there were tens of thousands of differentially expressed genes (DEGs) between each group. Afterwards, we selected 39 flavonoids and related metabolites (e.g., kaempferol-3-O-glucoside, quercetin 3-β-D-glucoside, rutin) for targeted metabolomics validation and performed RT-qPCR validation on 29 key flavonoid synthesis genes (e.g., C4H, CHS, FLS, F3'H) to verify the reliability of non-targeted metabolomics and transcriptomics.

conclusionsThis work indicated that leaves are the main site for the biosynthesis of flavonoids in Paris polyphylla Sm. Among them, kaempferol-3-O-glucoside, quercetin 3-β-D-glucoside, rutin, and other flavonoids are present in higher contents in leaves (P < 0.05). Further research on its biosynthetic mechanism indicates that naringenin chalcone is converted to naringenin by chalcone isomerase (CHI). Among them, CHI may be the rate-limiting enzyme in the biosynthesis of flavonoids in Paris polyphylla Sm. The expression of FLS is higher in leaves (P < 0.05) and tends to promote the synthesis of flavonols. This work promotes the utilization of non-medicinal parts of Paris polyphylla Sm. and enhances the sustainable development of this precious traditional Chinese medicine resource.

Indexed as

FlavonoidsLiliaceaeMelanthiaceaePlant LeavesGene Expression ProfilingGene Expression Regulation, PlantMetabolomeMetabolomicsPlant RootsPlant StemsTranscriptomeFlavonoidsBiosynthesisFlavonoidsMetabolomicsParis polyphylla sm.Transcriptomics

Identifiers

PMID41057796
PMCPMC12502438

What Socratic holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.